Exploring Mild Electrical Vestibular Stimulation as a New Treatment for Dizziness and Migraine Symptoms

Inclusion Criteria: * Clinical diagnosis of VM, according to the ICHD-3 and Barany Society criteria. * Experienced at least one vestibular migraine episode in the previous month. * Ability to provide informed consent and comply with study requirements. * Willingness to attend six EVS sessions over a two-week period and complete all required testing and diaries. * Physical ability to stand unassisted for at least one minute and walk 25 feet without assistance. Exclusion Criteria: * Diagnosis of other vestibular disorders (e.g. benign paroxysmal positional vertigo, Meniere's disease, vestibular neuritis) that may confound results. * History of seizure disorder, epilepsy, or unexplained loss of consciousness. * Presence of implanted electronic medical devices, such as pacemakers or cochlear implants. * Pregnancy or plans to become pregnant during study period. * Use of vestibular suppressant or migraine prophylactic medications that cannot be paused or maintained at a stable dose during the two-week EVS intervention period. Acute use of rescue medications during a severe attack is permitted, however, participants who initiate new medication or undergo dose changes during the intervention window will be excluded from final analysis. * Current medical, psychiatric, or neurological condition (other than VM) that could interfere with participation. * Cognitive or language impairments that preclude understanding of instructions or valid completion of outcome measures.